Daniel Edmonston MD MHS, FASN
Assistant Professor of Medicine, Duke University School of Medicine | Nephrologist, Duke University Hospital | Faculty, Duke Clinical Research Institute
Join to View Full Profile
300 W. Morgan StreetOffice 522Durham, NC 27701
Dr. Edmonston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Nephrology, 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2013 - 2016
Mercer University School of MedicineClass of 2013
Certifications & Licensure
NC State Medical License 2016 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- Trends in Steroidal Mineralocorticoid Receptor Antagonist Prescriptions by Nephrologists after Approval of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finer...Daniel Edmonston, Benjamin Catanese, Matthew Sparks
Journal of the American Society of Nephrology. 2025-08-18 - Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.Daniel Edmonston, Tamara Isakova, Laura M Dember, Sophia Waymyers, Davy Andersen
Journal of the American Society of Nephrology. 2025-07-10 - 5 citationsGlucarpidase for treatment of high-dose methotrexate toxicity.Shruti Gupta, Sarah A Kaunfer, Kevin L Chen, Julie-Alexia Dias, Anitha Vijayan
Blood. 2025-04-24
Press Mentions
Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 DiabetesAugust 19th, 2024- Kidney, CV Outcomes Similar for SGLT2 Inhibition vs. GLP-1s for DiabetesAugust 12th, 2024
- Highlights from the June 2021 IssueJune 1st, 2021
- Join now to see all
Grant Support
- Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)DUKE UNIVERSITY2021–2026
External Links
- Faculty Pagehttps://medicine.duke.edu/profile/daniel-len-edmonston
- Clinical Pagehttps://www.dukehealth.org/find-doctors-physicians/daniel-edmonston-md-mhs
- Scholars Pagehttps://scholars.duke.edu/person/daniel.edmonston
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
